BioCardia Inc (BCDA)
2.135
+0.14
(+7.29%)
USD |
NASDAQ |
Nov 21, 16:00
2.15
+0.02
(+0.70%)
After-Hours: 20:00
BioCardia Price to Book Value: 3.580 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 3.314 |
| November 19, 2024 | 3.380 |
| November 18, 2024 | 3.414 |
| November 15, 2024 | 3.081 |
| November 14, 2024 | 3.355 |
| November 13, 2024 | 3.913 |
| November 12, 2024 | 3.996 |
| November 11, 2024 | 3.83 |
| November 08, 2024 | 3.763 |
| November 07, 2024 | 3.939 |
| November 06, 2024 | 3.996 |
| November 05, 2024 | 4.046 |
| November 04, 2024 | 3.911 |
| November 01, 2024 | 3.927 |
| October 31, 2024 | 3.829 |
| October 30, 2024 | 3.894 |
| October 29, 2024 | 3.977 |
| October 28, 2024 | 4.322 |
| October 25, 2024 | 3.977 |
| October 24, 2024 | 3.944 |
| October 23, 2024 | 4.075 |
| October 22, 2024 | 4.272 |
| October 21, 2024 | 4.404 |
| October 18, 2024 | 4.420 |
| October 17, 2024 | 4.355 |
| Date | Value |
|---|---|
| October 16, 2024 | 4.33 |
| October 15, 2024 | 4.010 |
| October 14, 2024 | 4.256 |
| October 11, 2024 | 4.355 |
| October 10, 2024 | 4.437 |
| October 09, 2024 | 4.404 |
| October 08, 2024 | 4.355 |
| October 07, 2024 | 4.420 |
| October 04, 2024 | 4.502 |
| October 03, 2024 | 4.618 |
| October 02, 2024 | 4.535 |
| October 01, 2024 | 4.897 |
| September 30, 2024 | 5.127 |
| September 27, 2024 | |
| September 26, 2024 | |
| September 25, 2024 | |
| September 24, 2024 | |
| September 23, 2024 | |
| September 20, 2024 | |
| September 19, 2024 | |
| September 18, 2024 | |
| September 17, 2024 | |
| September 16, 2024 | |
| September 13, 2024 | |
| September 12, 2024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.151
Minimum
Dec 16 2021
37.63
Maximum
Jul 11 2023
7.242
Average
4.374
Median
Aug 04 2020
Price to Book Value Benchmarks
| Alnylam Pharmaceuticals Inc | 983.88 |
| The Cooper Companies Inc | 2.511 |
| Theriva Biologics Inc | 0.1446 |
| Zevra Therapeutics Inc | 6.996 |
| Instil Bio Inc | 0.9085 |
Price to Book Value Related Metrics
| PS Ratio | 9.898 |
| Price | 2.135 |
| Earnings Yield | -196.3% |
| Market Cap | 9.788M |